科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握数几十种专业技能,齐心协力,确保高品质治疗与成功康复。

治疗此病症的医生

编辑搜索过滤条件
Close

缩小搜索范围

重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: H

  1. Michael G. Haddock, M.D.

    Michael G. Haddock, M.D.

    1. Radiation Oncologist
    1. Rochester, MN
    擅长领域:

    Brachytherapy, External beam radiation therapy, IMRT, Intraoperative radiation therapy, Proton therapy, Vaginal cancer,... Liver cancer, Anal cancer, Endometrial cancer, Metastatic colorectal cancer, Hilar cholangiocarcinoma, Cervical cancer, Ovarian cancer, Soft tissue sarcoma, Chondrosarcoma, Sarcoma, Rectal melanoma, Cholangiocarcinoma, Duodenal cancer, Esophageal cancer, Pancreatic cancer, Rhabdomyosarcoma, Ewing sarcoma, Bone cancer, Leiomyosarcoma, Vulvar cancer, Rectal cancer, Colon cancer, Stomach cancer, Small bowel cancer, Ampullary cancer

  2. Christopher (Chris) L. Hallemeier, M.D.

    Christopher (Chris) L. Hallemeier, M.D.

    1. Radiation Oncologist
    1. Rochester, MN
    擅长领域:

    Stereotactic body radiotherapy, IMRT, Proton therapy, 3D conformal radiotherapy, Colon cancer, Liver cancer, Stomach ca...ncer, Anal cancer, Pancreatic cancer, Esophageal cancer, Rectal cancer

  3. Joleen M. Hubbard, M.D.

    Joleen M. Hubbard, M.D.

    1. Oncologist
    1. Rochester, MN
    擅长领域:

    Hepatic artery infusion pump chemotherapy, Rectal cancer, Esophageal cancer, Cholangiocarcinoma, Stomach cancer, Pancre...atic cancer, Hepatocellular carcinoma, Anal cancer, Colon cancer

研究

妙佑医疗国际的医生和科学家正在研究诊断和治疗直肠癌的新方法。详细了解胃肠癌研究的信息。

妙佑医疗国际癌症中心合作开展癌症研究。妙佑医疗国际癌症中心获得美国国家癌症研究所的资助,是指定的综合性癌症中心 — 这是对其致力于癌症预防、诊断和治疗的科学卓越成就和多学科资源的认可。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在直肠癌领域的文献目录

Research Profiles

缩小搜索范围

在 Mayo Clinic 治疗

May 18, 2022

Living with 直肠癌?

Connect with others like you for support and answers to your questions in the Colorectal Cancer support group on Mayo Clinic Connect, a patient community.

Colorectal Cancer Discussions

Becky, Volunteer Mentor
The Patient Portal—Help or Hindrance?

83 Replies Tue, Nov 01, 2022

See more discussions